Clinical Trial Update: A Study of SKB575 (HBM7575) Injection in Healthy Participants and Atopic Dermatitis Participants [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating SKB575 (HBM7575) injections in healthy participants and participants with atopic dermatitis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• SKB575 (HBM7575) (HBM7575)

Snippet

Sponsor: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | Conditions: Atopic Dermatitis | Phase 1 | Status: RECRUITING